Cosmetics Stakeholders Race To Hitch Reform Provisions To FDA User-Fee Bills
This article was originally published in The Rose Sheet
The Personal Care Products Council says consensus has nearly been reached between industry and consumer advocates on cosmetics reform provisions they hope to attach to FDA user-fee legislation. The groups must produce broadly supported, noncontroversial language by mid-March in order to have a shot at inclusion in the critical reauthorization bills, which typically pass well in advance of October deadlines.
You may also be interested in...
With the release of an atypically lean, clean FDA user-fee reauthorization draft bill, it’s doubtful that cosmetics regulatory reform language will get tacked onto the must-pass legislation. Stakeholders likely will refocus their efforts on standalone cosmetics legislation to modernize FDA’s oversight of the industry.
President Trump appears to want greater user-fee contributions from FDA-regulated industries to offset cuts to federal spending in fiscal 2018. His recently released budget blueprint could complicate negotiations that cosmetics stakeholders were hoping to join, but it also could signal opportunity for an industry seeking increased regulation – and willing to pay for it.
The Personal Care Products Council has a vision for marrying the Cosmetic Ingredient Review’s expertise with FDA’s authority, which it hopes to package into reform legislation expected this year. While FDA has balked at formalizing CIR’s role under previous proposals, this one was inspired by a third-party review program for medical devices, making it potentially more palatable to the agency and lawmakers.